SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare Announce Approval of EYLEA® (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia